Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
ALL, Biological, Leukemia, SARS-CoV-2/COVID-19, CLL, Diseases, Lymphoma (any), CAR-Ts, Mantle Cell Lymphoma, Therapies, Non-Hodgkin Lymphoma, Biological Processes, cell expansion, T-Cell Lymphoma, Technology and Procedures, immunotherapy, Lymphoid Malignancies, Clinically relevant, hematopoiesis, flow cytometry, immune mechanism, mass cytometry, molecular interactions
Type: Oral
Hematology Disease Topics & Pathways:
ALL, Biological, Leukemia, SARS-CoV-2/COVID-19, CLL, Diseases, Lymphoma (any), CAR-Ts, Mantle Cell Lymphoma, Therapies, Non-Hodgkin Lymphoma, Biological Processes, cell expansion, T-Cell Lymphoma, Technology and Procedures, immunotherapy, Lymphoid Malignancies, Clinically relevant, hematopoiesis, flow cytometry, immune mechanism, mass cytometry, molecular interactions
Monday, December 7, 2020: 7:00 AM-8:30 AM
Moderators:
Jennifer N. Brudno, MD, National Cancer Institute, National Institutes of Health
and
Nathan Singh, MD, University of Pennsylvania
Disclosures:
No relevant conflicts of interest to declare.
7:00 AM
7:15 AM
7:30 AM
8:00 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH